Oral antineoplastic agents: how do we care about adherence?

Author:

Barillet Marie1,Prevost Virginie234,Joly Florence234,Clarisse Bénédicte4

Affiliation:

1. Centre Hospitalier J Monod; rue Eugène Garnier BP 219 61104 Flers cedex

2. Université de Caen Basse-Normandie EA 3936; Esplanade de la Paix, BP 5186 14032 Caen Cedex 05

3. INSERM U1086, Cancers et Préventions; Avenue de la Côte de Nacre F-14000 Caen

4. Centre Régional de Lutte Contre le Cancer François Baclesse; 3 Avenue du Général Harris 14000 Caen France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference96 articles.

1. Sabaté E. Adherence to Long-Term Therapies: Evidence for Action 2003 http://apps.who.int/medicinedocs/pdf/s4883e/s4883e.pdf

2. Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring;Waterhouse;J Clin Oncol,1993

3. A changing paradigm for cancer treatment: the advent of new oral chemotherapy agents;Bedell;Clin J Oncol Nurs,2003

4. Oral cancer treatment: developments in chemotherapy and beyond;O'Neill;Br J Cancer,2002

5. Targeted cancer therapy;Sawyers;Nature,2004

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3